EBITDA: Income before interest, taxes, depreciation and amortization.
Lombard Medical, Inc. (EVARF) had EBITDA of $-23.38M for the most recently reported fiscal year, ending 2016-12-31.
| Income Statement Financials | |
$12.17M |
|
$-31.04M |
|
$11.03M |
|
$1.14M |
|
$37.69M |
|
$-25.52M |
|
$-7.00M |
|
$-32.52M |
|
$-29.16M |
|
$-31.04M |
|
$-31.04M |
|
$-31.04M |
|
$-27.52M |
|
$-25.52M |
|
|
EBITDA |
$-23.38M |
20.17M |
|
20.17M |
|
$-1.54 |
|
$-1.54 |
|
| Balance Sheet Financials | |
$33.58M |
|
$1.37M |
|
$34.18M |
|
$67.77M |
|
$10.07M |
|
$28.02M |
|
$43.72M |
|
$53.79M |
|
$13.97M |
|
$-18.84M |
|
$13.97M |
|
27.95M |
|
| Cash Flow Statement Financials | |
$-25.20M |
|
$-0.09M |
|
$15.81M |
|
$32.33M |
|
$20.80M |
|
$-11.54M |
|
$1.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.33 |
|
-- |
|
-- |
|
0.67 |
|
2.31 |
|
9.38% |
|
-209.72% |
|
-209.72% |
|
-192.15% |
|
-267.20% |
|
-255.03% |
|
$-25.34M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
1.60 |
|
2.06 |
|
177.27 |
|
-222.11% |
|
164.76% |
|
-45.80% |
|
-73.90% |
|
$0.50 |
|
$-1.26 |
|
$-1.25 |
|